Catalyst Wire Dossier Catalyst Wire Dossier

LV232 capsules

LV232 · Vigonvita Life Sciences
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LV232 capsules, covering 2025-04-24 to 2025-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LV232 Capsules in the Treatment of MDD [Phase 2]

See pricing